Company intelligence / Profile preview

Fork & Good

Jersey City, New Jersey, United Statesforkandgood.com ↗

Ownership: Private
Development stage: Commercial

Overview

Fork & Good has developed a patented process to cultivate pork muscle cells directly in proprietary bioreactors. Their approach allows higher yield and density compared to traditional methods. The company’s Jersey City pilot facility can produce six to ten times more pork per square foot than conventional farming. They have conducted successful tastings of hybrid cultivated/conventional pork blends at events such as Davos. Products are pending regulatory approval before commercial launch.

Therapeutic areas: Other
Modalities: Cell-based meat productionCultivated meat (muscle cell cultivation in bioreactors)
Industry: Non-Drug Biotech

Partnerships

None disclosed with major pharma/biotech; discussions with large global meat producers ongoing

Beyond the preview

Go deeper on Fork & Good.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fork & Good.

Explore the full profile